Veru Inc. (NASDAQ:VERU - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.60 and traded as low as $0.60. Veru shares last traded at $0.67, with a volume of 4,062,566 shares changing hands.
Veru Stock Performance
The stock has a market cap of $85.24 million, a P/E ratio of -2.42 and a beta of -0.80. The firm has a 50 day simple moving average of $0.56 and a two-hundred day simple moving average of $0.60.
Veru (NASDAQ:VERU - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.01. Veru had a negative return on equity of 128.51% and a negative net margin of 223.85%. As a group, equities research analysts predict that Veru Inc. will post -0.22 EPS for the current year.
Hedge Funds Weigh In On Veru
A number of hedge funds have recently modified their holdings of the stock. MPM Bioimpact LLC grew its holdings in shares of Veru by 53.8% in the 1st quarter. MPM Bioimpact LLC now owns 6,592,727 shares of the company's stock worth $3,231,000 after acquiring an additional 2,307,362 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Veru by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 2,997,751 shares of the company's stock worth $1,950,000 after acquiring an additional 57,611 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Veru by 17.0% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 1,423,288 shares of the company's stock worth $698,000 after acquiring an additional 206,614 shares during the last quarter. Oppenheimer & Co. Inc. grew its holdings in shares of Veru by 18.3% in the 1st quarter. Oppenheimer & Co. Inc. now owns 1,325,246 shares of the company's stock worth $650,000 after acquiring an additional 204,660 shares during the last quarter. Finally, PVG Asset Management Corp grew its holdings in shares of Veru by 64.4% in the 4th quarter. PVG Asset Management Corp now owns 1,047,310 shares of the company's stock worth $681,000 after acquiring an additional 410,340 shares during the last quarter. 47.16% of the stock is currently owned by institutional investors and hedge funds.
Veru Company Profile
(
Get Free Report)
Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Read More
Before you consider Veru, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veru wasn't on the list.
While Veru currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
